SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-002770
Filing Date
2014-01-17
Accepted
2014-01-17 15:38:36
Documents
1
Period of Report
2014-01-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v365710_4.html 4  
1 OWNERSHIP DOCUMENT v365710_4.xml 4 3077
  Complete submission text file 0001144204-14-002770.txt   4779
Mailing Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107
Business Address C/O JANSSEN LABS @ QB3 953 INDIANA STREET SAN FRANCISCO CA 94107 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Issuer) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 675 ALMANOR AVENUE SUNNYVALE CA 94085
Business Address
COMMISSIONG GERALD (Reporting) CIK: 0001566928 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55016 | Film No.: 14534960